Jul 2026· Journal of Immunology· Vol 215· 0 citations
Abstract
Targeted immunotherapies aimed at enhancing antiviral T cell responses are of particular interest for treating neurotropic viral infections such as West Nile Virus (WNV), which lacks a licensed human vaccine. Previous studies have shown that DEC-205+ dendritic cells (DCs) in the central nervous system (CNS) play a role in reactivating antiviral immunity during WNV infection.
Methods to investigate this: a hybrid scFv antibody targeting DEC-205 and conjugated to a peptide from the WNV NS4b protein was administered to mice infected with WNV-TX. Poly I:C was co-delivered as an adjuvant to promote DC maturation. Immunological outcomes were assessed by quantifying co-stimulatory molecule expression (CD40, CD80, CD86) on DCs and evaluating T cell activation markers and cytokine profiles.
Mice receiving the DEC-205—NS4b scFv showed increased expression of activation markers and higher levels of pro-inflammatory cytokines, suggesting enhanced antiviral immunity.
These findings support targeted DC-based strategies as a promising approach for future WNV vaccine development.
Cal Poly Pomona Project Hatchery
Immune Response Regulation: Cellular Mechanisms (IRC)
This work investigates the potential of IVAX-1, a combination of TLR4 (MPLA) and TLR9 (CpG 1018) agonists formulated in a squalene oil-in-water emulsion, to mediate protection and generate CMI and demonstrates the potential of TLR agonist combinations to elicit durable T-cell immunity.
Dan Nguyen, D. Davies, J. Felgner et al.· Journal of Immunology· 0 citations
Cross-presentation (XPT) is pivotal for inducing antigen (Ag)-specific CD8+ T cell responses, which is linked to better therapeutic outcomes. However, in the context of therapeutic vaccination, how to promote T cell cross-priming in vivo remains unclear. This motivates elucidating the mechanisms underlying XPT by...
Yu-Chi Huang, Pei-Chuan Chiang, C. Tsai et al.· Journal of Immunology· 0 citations
Dengue virus rNS3pro immunization drives a robust expansion of multifaceted regulatory-like T-cell phenotypes, identifying the NS3 protease domain as a potential player in DENV immune evasion strategies.
V. Romero-Cruz, A. Ramos-Ligonio, Diana Lizzet Murrieta-León et al.· Acta Tropica· 0 citations
It is demonstrated that PAR-2 activation functions as a potent mucosal adjuvant by enhancing early immune cell recruitment, DC activation, and adaptive T cell responses in lymph nodes, ultimately promoting tissue-resident immunity.
C. Kornuta, Gang Zhou, K. Kane et al.· Vaccine· 0 citations
Investigating how the vaccine shapes the CD4+ T cell immunity and how these responses cooperate in reducing the acquisition found that DV1 DNA/ALVAC/gp120 vaccine elicited envelope-specific immunomodulatory Tr1 CD4+ T cells, and that total Tr1 responses were associated with a reduced risk of viral acquisition.
Massimiliano Bissa, S. Fourati, Sohyoung Kim et al.· Journal of Immunology· 0 citations
It is demonstrated that the optimal induction of CD8 T-cells requires IFN-I signaling in multiple myeloid cell types, not just in CD8 T-cells, dendritic cells, or monocytes, and that regulation of IFN-β by NF-κB and all IFN-I subtypes by IRF is required to induce protective CD8 T-cells.
Samit Kafle, Brian Montoya, Carolina R. Melo-Silva et al.· Journal of Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
